Ansell Healthcare Products LLC announces it has won a silver MM&M (Medical Marketing & Media) award this fall in recognition of its “Power of Pink” campaign for the launch of its Micro-Touch® NitraFree™ nitrile exam gloves.
MM&M announced the honor at its 2009 Award Show, held October 29 at in New York City. The awards recognize the marketing and advertising effectiveness of healthcare companies throughout the United States.
“A great, simple idea,” said judges for the MM&M Award, who included senior executives from Merck, Pfizer, Johnson & Johnson, Novartis, AstraZeneca and other leading healthcare companies. More than 700 submissions were considered for awards this year.
The “Power of Pink” campaign was aimed at generating awareness among healthcare personnel in hospitals and clinics for Ansell's “anti-allergies” nitrile examination glove, Micro-Touch® NitraFree™, and promoting a fundraising partnership with Susan G. Komen for the Cure®, the world’s largest breast cancer advocacy organization.
Creative director Todd Mecca said, “Our primary goal was to create an effective marketing campaign that would truly engage Ansell’s audience; a campaign that gave everyone the opportunity to support this worthy cause. Many members of our team at Q&B have had a brush with this horrible disease, so we understand the importance of making even a small difference in the fight for the cures. Empowering the healthcare community to make a difference was critical to the success of the campaign – we wanted to give them the opportunity to partner with Ansell and Susan G. Komen for the Cure to help win the battle. We gave practitioners a way to share their emotions, and love at AORN 2008 and 2009 by signing a hand and displaying it upon the Wall of Empowerment for 5,000 of their peers to share.”
For each glove affixed to the wall, Ansell donated $1 to Susan G. Komen for the Cure. At the same time, nurses learned how the sale of every Micro-Touch® NitraFree™ glove would continue to support breast cancer awareness and research through Komen for the Cure.
“We are so proud to be honored for this campaign,” said Patty Taylor, vice president of marketing – North America, of Ansell Healthcare. “Not only did we make a big impact with an important new product that will help healthcare practitioners do their jobs more safely and effectively – but it’s so gratifying to be raising funds and awareness for Susan G. Komen for the Cure at the same time.”
“This campaign was rewarding in so many ways,” explained Emily Spensieri, president of Q&B Healthcare. “Our first reward came at the trade show, experiencing the incredible sense of community created at the Wall of Empowerment when nurses came together to share their stories. Then came the rewards of unprecedented leads – and the sales that followed. And now, being recognized for the MM&M award? It’s the cherry on top. We are so pleased to have won this award for a campaign that’s so close to our hearts.”
Balancing Freedom and Safety: When Public Health Mandates Are Necessary
January 9th 2025Public health mandates, such as lockdowns, masking, and vaccination, balance liberty and safety, ensuring critical protections during pandemics like COVID-19 while fostering long-term survival through science.
Avian Flu Risks in Veterinary Practice: Protecting Those on the Frontlines
January 6th 2025Veterinarians, technicians, and veterinarian infection preventionists face risks from H5N1 avian flu when handling farm animals or exposed wildlife. Learn key prevention strategies, PPE recommendations, and emerging challenges.
Understanding the True Threat: Richard Webby, PhD, on H5N1 Avian Flu and Its Human Impact
January 3rd 2025Richard Webby, PhD, the director of the World Health Organization (WHO) Collaborating Centre or Studies on the Ecology of Influenza in Animals and Birds, discusses the evolving dynamics of H5N1 avian flu, its variants, and the low risk to humans while emphasizing vigilance among health care professionals.
Addressing Post-COVID Challenges: The Urgent Need for Enhanced Hospital Reporting Metrics
December 18th 2024Explore why CMS must expand COVID-19, influenza, and RSV reporting to include hospital-onset infections, health care worker cases, and ER trends, driving proactive prevention and patient safety.